391 related articles for article (PubMed ID: 9510127)
21. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity.
Miller A; Arthurs B; Boucher A; Liberman A; Bernard N; Rodien P; Salvi M; Wall JR
Thyroid; 1992; 2(3):197-202. PubMed ID: 1422231
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies reactive with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy.
Bednarczuk T; Stolarski C; Pawlik E; Slon M; Rowinski M; Kubota S; Hiromatsu Y; Bartoszewicz Z; Wall JR; Nauman J
Thyroid; 1999 Mar; 9(3):289-95. PubMed ID: 10211607
[TBL] [Abstract][Full Text] [Related]
23. Serum antibodies reactive with eye muscle membrane antigens are detected in patients with nonspecific orbital inflammation.
Atabay C; Tyutyunikov A; Scalise D; Stolarski C; Hayes MB; Kennerdell JS; Wall J
Ophthalmology; 1995 Jan; 102(1):145-53. PubMed ID: 7831030
[TBL] [Abstract][Full Text] [Related]
24. Serological reactivity of recombinant 1D autoantigen and its expression in human thyroid and eye muscle tissue: a possible autoantigenic link in Graves' patients.
Kromminga A; Hagel C; Arndt R; Schuppert F
J Clin Endocrinol Metab; 1998 Aug; 83(8):2817-23. PubMed ID: 9709953
[TBL] [Abstract][Full Text] [Related]
25. A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin.
Gunji K; Kubota S; Stolarski C; Wengrowicz S; Kennerdell JS; Wall JR
Autoimmunity; 1999; 29(1):1-9. PubMed ID: 10052680
[TBL] [Abstract][Full Text] [Related]
26. Isotype and immunoglobulin subclass distribution of eye muscle membrane reactive antibodies in the serum of patients with thyroid-associated ophthalmopathy as detected in Western blotting.
Bernard NF; Ertug F; Teboul N; Zhang ZG; Salvi M; Wall JR
Autoimmunity; 1991; 10(1):57-63. PubMed ID: 1742423
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
[TBL] [Abstract][Full Text] [Related]
28. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
29. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.
Gopinath B; Ma G; Wall JR
Thyroid; 2007 Nov; 17(11):1123-9. PubMed ID: 17887926
[TBL] [Abstract][Full Text] [Related]
30. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
31. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
[TBL] [Abstract][Full Text] [Related]
32.
Sun B; Zhang Z; Dong C; Zhang Y; Yan C; Li S;
Eye (Lond); 2017 May; 31(5):668-676. PubMed ID: 28387769
[TBL] [Abstract][Full Text] [Related]
33. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy.
Hiromatsu Y; Fukazawa H; Guinard F; Salvi M; How J; Wall JR
J Clin Endocrinol Metab; 1988 Sep; 67(3):565-70. PubMed ID: 3410941
[TBL] [Abstract][Full Text] [Related]
34. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
Mizokami T; Salvi M; Wall JR
J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
[TBL] [Abstract][Full Text] [Related]
35. [The role of antibodies in Graves' ophthalmopathy].
Molnár I; Balázs C
Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
[TBL] [Abstract][Full Text] [Related]
36. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
Adler G
Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
[TBL] [Abstract][Full Text] [Related]
37. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the IgG autoantibody repertoire in endocrine ophthalmopathy using the MegaBlot technique.
Grus FH; Augustin AJ
Curr Eye Res; 1998 Jun; 17(6):636-41. PubMed ID: 9663853
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blood lymphocyte transformation to G2s in patients with autoimmune thyroid disease with and without ophthalmopathy.
Chang CH; Yamada M; Blanchard ME; Li AW; Wall JR
Autoimmunity; 2002 Aug; 35(5):313-7. PubMed ID: 12515285
[TBL] [Abstract][Full Text] [Related]
40. Nature of 64 kDa eye muscle and thyroid membrane proteins and their significance in thyroid-associated ophthalmopathy--an hypothesis.
Boucher A; Bernard N; Zhang ZG; Rodien P; Salvi M; Wall JR
Autoimmunity; 1993; 16(2):79-82. PubMed ID: 8180320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
